Overview of Nuflor

Nuflor is the trade name for an injectable, prescription-only synthetic antibiotic whose single active ingredient is Florfenicol. It is fundamentally a specialized veterinary medicine designed for systemic use to help control and manage bacterial infections in livestock.

Quick Facts

Property	Description
Active Ingredient	Florfenicol
Form	Injectable Solution (Sterile Liquid)
Pharmacological Class	Phenicol Antibiotic
Common Use (General)	Management of Bacterial Infections
Origin	Synthetic (Thiamphenicol Derivative)

Defining Florfenicol: Class, Origin, and Purpose

Florfenicol is the core active medicinal substance in Nuflor, classified as a Phenicol class antibiotic. This synthetic drug is a modified derivative of Thiamphenicol, developed to be an optimized analogue of the older antibiotic Chloramphenicol, with chemical adjustments engineered to potentially overcome certain bacterial resistance mechanisms.

The drug's action is primarily bacteriostatic, meaning it does not necessarily kill the bacteria directly but stops their ability to grow and multiply by interfering with their internal processes. Florfenicol is chemically designed for enhanced tissue penetration to target Gram-negative bacteria effectively. This widely-recognized property indicates the medicine is well-suited for reaching and managing difficult internal infections often encountered in cattle.

The general purpose of Florfenicol is to act as a broad-spectrum antimicrobial agent, providing essential support in managing bacterial proliferation and mitigating the negative effects of infection in its targeted animal populations.

Composition and Form: What is Florfenicol Made Of?

Nuflor is supplied as a single-ingredient product in a clear injectable solution format, which is a sterile liquid intended for parenteral administration by a veterinarian. This high-level form dictates that the medication is delivered by injection rather than through the digestive system, facilitating rapid and predictable absorption. The active ingredient, Florfenicol, is dissolved within a pharmaceutical vehicle, primarily Propylene Glycol, which acts as the solvent base to ensure stability and proper delivery of the medication throughout the body. The veterinary-grade designation highlights the drug’s specific formulation and regulatory approval for use exclusively in livestock.

What side effects are possible with Nuflor?

Possible Side Effects and Safety Information

The official safety information for Florfenicol (Nuflor) as a veterinary medicine categorizes possible adverse reactions into systemic, gastrointestinal, and administration site effects. Many of the adverse reactions observed are classified as transient, meaning they occur for a limited time following treatment.

Transient effects commonly reported in regulatory documents include decreased food consumption (inappetence), decreased water consumption, and diarrhea or soft feces. These are generally mild, temporary disturbances of the gastrointestinal system.

Administration of the injectable solution can result in a local tissue reaction at the injection site. This specific reaction is officially documented to persist beyond 28 days following injection, distinguishing it as a long-term, localized effect. This persistence may result in trim loss of edible tissue at slaughter, a documented safety note related to its use.

Category	Officially Documented Reactions (Examples)
Transient Effects	Decreased food and water consumption, diarrhea
Persistent Local Effect	Local tissue reaction at injection site
Serious Reactions	Anaphylaxis, collapse, dose-related hematopoietic tissue decreases

Serious adverse reactions, though rare, include the potential for systemic events such as anaphylaxis and collapse. Furthermore, safety studies have noted a dose-related decrease in hematopoietic/lymphopoietic tissue.

Population-Specific Prohibitions are strict safety constraints on use. The medicine is prohibited in female dairy cattle 20 months of age or older and in calves intended for processing for veal. It is also not for use in animals intended for breeding purposes. The compound is contraindicated in animals with a history of hypersensitivity to florfenicol.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Florfenicol overdose focuses on documented clinical signs in the target animal species and mandated emergency actions for human exposure. Overdosage in livestock has been documented to cause dose-dependent clinical manifestations, including decreased food consumption and softened faeces. In swine, administration at high multiples of the recommended dose has resulted in vomiting. Furthermore, prolonged, high-level exposure is regulatory classified with the potential for target organ damage, affecting systems such as the liver, brain, and reproductive organs.

The established management protocol for overdosage is symptomatic and supportive treatment, as regulatory documents explicitly state that no specific antidote is known. This structural constraint directs all management efforts toward clinical support.

A key regulatory requirement within the overdose context concerns accidental human exposure. If accidental self-injection or ingestion of the injectable solution occurs, the regulatory label mandates that the individual seek medical advice immediately and show the product label to the physician. Similarly, immediate veterinary advice must be sought for any suspected animal overdosage.

Therapeutic Uses of Nuflor

What Nuflor Treats: Main Uses and Benefits

The injectable solution containing Florfenicol is applied across several core therapeutic domains where systemic bacterial infection causes symptoms that create noticeable physiological strain in livestock. The medicine plays a role in managing these manifestations.

Nuflor is used across therapeutic domains involving acute or disruptive symptom patterns, where symptoms are caused by susceptible bacteria.

The primary therapeutic application is to manage symptoms related to systemic imbalance in cattle and swine across conditions involving acute or disruptive episodes, such as Bovine Respiratory Disease (BRD), Foot Rot (interdigital necrobacillosis), and specific syndromes like infectious Pinkeye. The medication is commonly used in clinical settings that involve acute or unstable symptom patterns, such as those related to heightened systemic burden during periods of stress.

“Applied in settings marked by temporary physiological imbalance, this medication provides support that helps ease the overall symptom load.”

Symptom Relief and Therapeutic Support

This medication is applied when animals show pronounced manifestations like difficulty breathing, fever, lameness, and depression, which are symptoms related to systemic imbalance or physical discomfort. When applied in these conditions, Nuflor may assist with maintaining a sense of stability and contributes to easing the overall symptom load during periods of heightened symptoms. This supportive relief assists with maintaining functional stability when symptoms interfere with routine activities.

Summary: Support for Symptom Management

Category	Typical Symptoms Managed	Primary Therapeutic Benefit
Respiratory	Coughing, difficulty breathing, nasal discharge	Helps ease the overall symptom load
Musculoskeletal	Severe lameness, inability to bear weight	Assists with maintaining a sense of stability
Systemic	Fever, anorexia (appetite loss), depression	Contributes to easing the overall symptom load

Regulatory References

Health Canada Product Information

Eligibility and Restrictions for Use

Nuflor (florfenicol) is an antibiotic approved for use in specific food-producing animals, and its eligibility is strictly controlled by veterinary and regulatory bodies.

Populations for Whom Use is Prohibited or Contraindicated

Use of this medicine is contraindicated in any animal that has shown a known hypersensitivity or allergy to florfenicol or any of its excipients. Regulatory documents expressly prohibit its use in the following classes of animals:

Female Dairy Cattle 20 Months of Age or Older: Including dry cows, to prevent drug residues in milk destined for human consumption.
Calves to be Processed for Veal: A withdrawal period has not been established for this class, making their use prohibited.
Breeding Animals: Use is not recommended or prohibited in adult bulls, rams, boars, or fish intended for breeding purposes, as the effects on reproductive performance are undetermined.

Use During Pregnancy and Lactation

The safety of Nuflor has not been established during animal pregnancy or lactation. Therefore, regulatory labeling does not authorize its use in pregnant animals intended to produce milk for human consumption or in nursing piglets. All administrations are restricted by Federal law to use by or on the order of a licensed veterinarian.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Nuflor’s active ingredient, Florfenicol, has specific, officially documented interaction patterns that strictly regulate its co-administration with other substances. These restrictions are categorized across pharmacodynamic risk and administration-timing requirements as detailed in regulatory documents.

Pharmacodynamic Co-Administration Restrictions

Co-administration is formally prohibited with several pharmacological agents, including other antibiotics, indirect anticoagulants, barbiturates, and muscle relaxants. A further set of restrictions exists due to documented pharmacodynamic risk. Use is restricted when combined with Glucocorticoids, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), and Anticoagulant Agents. This restriction is based on an officially documented risk of additive effects, potentially leading to an increased incidence of haemorrhagic or ulcerogenic gastrointestinal lesions.

Administration-Timing and Excipient Rules

The injectable format of the medication carries a mandatory administration-timing rule. The sterile solution must not be mixed with any other veterinary medicinal products due to physical incompatibility, necessitating separation during the administration process. Finally, a documented interaction exists involving specific excipients in alternative formulations: the presence of Ground Limestone in Florfenicol oral premix is officially noted to decrease feed consumption and affect the expected balance of phosphorus and calcium. These constraints strictly define the product’s regulatory interaction profile.

Mechanism of Action

Nuflor contains the synthetic antimicrobial florfenicol, which is classified as a phenicol compound. Its primary biological target is the bacterial ribosome.

The molecule functions as an inhibitor by selectively binding to the 50S ribosomal subunit, specifically at the peptidyl transferase center, preventing the appropriate positioning of aminoacyl-tRNA.

This interaction blocks the enzyme peptidyl transferase, an essential component of the intracellular protein synthesis pathway. By inhibiting peptidyl transferase, florfenicol prevents the formation of peptide bonds between incoming amino acids and the nascent polypeptide chain. The downstream cascade is the cessation of bacterial protein elongation and, consequently, the suppression of synthesis for critical structural and enzymatic proteins. This modulation of essential intracellular machinery results in a system-level physiological consequence of bacteriostasis in susceptible microorganisms, which limits cellular replication and growth.

Dosage and Administration Information

How to Use Nuflor

Nuflor, the injectable 300 mg/mL Florfenicol solution, is administered exclusively via parenteral injection. The approved routes are Intramuscular (IM) injection and Subcutaneous (SC) injection, with the SC route reserved specifically for cattle. The general principles of use define two distinct treatment schedules based on the chosen route.

The administration is strictly weight-based, requiring the animal’s body weight to be accurately determined before use. For cattle, the SC regimen is a single-dose application of 40 mg/kg body weight. Conversely, the IM regimen for cattle requires a dose of 20 mg/kg body weight, administered twice with a 48-hour interval between injections. For swine, the approved regimen is IM administration at 15 mg/kg body weight, also requiring a second injection 48 hours after the first.

Regardless of the route, the injection site is strictly confined to the neck musculature. To ensure correct usage, a sterile needle and syringe must be used, and procedural constraints limit the volume per injection site to a maximum of 10 mL for cattle. Furthermore, the medication is not intended for use in breeding animals (such as bulls or boars) or in female dairy cattle 20 months of age or older.

Recent Clinical Evidence

Research evidence / Overview of studies for Nuflor (Florfenicol)

Evidence for use in Bovine Respiratory Disease (BRD)

Research examined Florfenicol for its potential application in cattle for Bovine Respiratory Disease (BRD), a condition associated with acute or disruptive episodes of respiratory symptoms. Studies relevant to BRD primarily include Randomized Controlled Trials (RCTs) conducted in field settings, alongside specialized Pharmacokinetic (PK) studies that map how the drug was observed to be absorbed and distributed throughout the animal's system. Research examined outcomes related to systemic or functional imbalance. Specifically, studies explored and monitored clinical measures such as the proportion of cattle not requiring re-treatment, often referred to in the research as the first-treatment endpoint.

Evidence is limited regarding outcomes over extended periods. Follow-up durations were typically limited to about four weeks (28 days) post-treatment. Research so far indicates that the data focus primarily on these short-term endpoints, and long-term outcomes beyond this initial period are not fully established.

Evidence for use in Foot Rot (Bovine Interdigital Phlegmon)

Florfenicol was studied for its use in cases of Foot Rot, a condition marked by functional limitations and local physical discomfort. The evidence base here is generally composed of research field trials and targeted PK studies. These studies were observed in cattle to assess outcomes related to physical discomfort, such as the change in lameness and change in the appearance of visible lesions.

Comparative evidence is lacking when Florfenicol is weighed against the entire spectrum of other approved treatments for this specific condition. The primary research provides limited insight into how long the observed changes persisted or the underlying pathological state after the initial study period concluded.

What is Still Uncertain About Florfenicol Research

While Florfenicol was studied for its core indications, several areas of uncertainty or research gaps persist. There is limited information for long-term outcomes, as follow-up durations were limited in many primary efficacy trials. Additionally, comparative evidence is lacking in certain areas against all other approved treatments for every specific indication, confirming that certainty remains low regarding outcomes beyond the specific, controlled conditions under which they were conducted.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Nuflor (FAQ)

Q: How quickly should I expect Nuflor to start working?

Clinical improvement is described in official documents as often observable in most treated subjects within 24 hours after the treatment is started. Official documentation states that if a positive response is not evident within 72 hours, the diagnosis should be re-evaluated.

Q: Does Nuflor treat bacterial infections other than the main ones listed?

The medicine is officially indicated for the treatment of specific infections, primarily Bovine Respiratory Disease (BRD) and bovine interdigital phlegmon (foot rot), caused by particular susceptible bacteria. The regulatory labels only list specific approved uses.

Q: How is Nuflor different from other common medications for similar issues?

Florfenicol, the active ingredient, is classified as a synthetic phenicol-class antibiotic. Regulatory studies indicate it was developed with chemical adjustments intended to prevent inactivation by certain bacterial resistance mechanisms associated with older compounds in its class.

Q: Is there a generic version of Nuflor available?

Yes, the active ingredient, florfenicol, is available from various manufacturers as a generic medication. These generic products are used for authorized animal species and indications, in addition to the brand name product, Nuflor.

Q: Do I need to finish the entire prescribed amount of Nuflor?

Regulatory documents emphasize that proper adherence to the complete, full treatment regimen is a key component of responsible use. Proper adherence is considered important to help limit the potential development of antimicrobial resistance.

Q: Is it okay to take Nuflor if I have a history of liver issues?

Safety studies are conducted to identify potential risks. Official data has noted dose-related effects on various organs, including the liver, following prolonged or repeated exposure to the florfenicol active ingredient. This documented risk is included in the safety information.

Q: How long does Nuflor stay in the system after the last use?

Pharmacokinetic studies, which track how the drug moves through the body, indicate that the drug's mean elimination half-life is approximately 18.3 hours following subcutaneous administration. This represents the time required for half the drug amount to be eliminated.

Q: What should be done if too much Nuflor is accidentally used?

Regulatory documents indicate that no specific emergency procedures or antidotes are known to be necessary for the animal species in question. High doses (e.g., three times the recommended amount) have been observed to cause temporary effects such as a reduction in food/water consumption and lethargy.

Q: Does Nuflor need to be taken with food?

The medicine is an injectable solution administered only by parenteral injection (intramuscular or subcutaneous), which bypasses the digestive system. Therefore, administration instructions regarding food are not relevant to the regulatory documents.

Q: Is it normal to feel a bit tired after starting Nuflor?

Tiredness or lethargy are not listed among the commonly reported side effects in official documentation for the recommended dose. However, lethargy was associated with the administration of doses that were three times the recommended amount.

Q: Are the side effects of Nuflor generally mild?

Official safety information documents two categories of effects: transient (temporary) effects, such as decreased food and water consumption, and the potential for rare but serious adverse reactions, including anaphylaxis and collapse.

Q: Is it possible to be allergic to Nuflor?

Yes, regulatory documents establish that use of the medicine is contraindicated (prohibited) in any animal that has previously shown a history of hypersensitivity (allergic reaction) to florfenicol or any of its components.

Q: What are the common signs of a Nuflor allergy?

Serious adverse reactions listed in the official safety information, which may be associated with hypersensitivity, include the potential for anaphylaxis (a severe whole-body reaction) and collapse.

Q: What should I do if my symptoms don't improve after a few days on Nuflor?

Official documentation states that if a positive response to treatment is not evident within 72 hours of the initial injection, the original diagnosis should be re-evaluated.

Q: Where can I find the official patient information leaflet for Nuflor?

The complete official safety and prescribing information (often called the product label or package insert) is publicly available. It can be found through governmental sources such as the U.S. Food and Drug Administration (FDA) DailyMed service, which hosts the drug label.

Q: Does the efficacy of Nuflor change depending on the person's age?

The regulatory label specifies that the medicine is prohibited in certain specific age-based populations, such as female dairy cattle 20 months of age or older and calves intended for veal. This indicates that age and developmental status are regulatory factors in its approved use.

Q: Are there any specific conditions where Nuflor use is strongly cautioned?

Regulatory documents list strict constraints on use, including prohibition in animals intended for breeding purposes (like adult bulls and rams) and female dairy cattle 20 months of age or older.

Q: Is Nuflor linked to resistance issues in bacteria?

Regulatory documents include cautionary statements. The cautionary statements emphasize that proper use is important to help limit the potential development of antimicrobial resistance.

Q: How do researchers measure the success of Nuflor in clinical trials?

Success in clinical research is documented using specific endpoints. These measurements include the proportion of subjects not requiring re-treatment for the condition, and changes in observable clinical signs such as lameness or the appearance of physical lesions.

Q: Can children or teenagers use Nuflor?

The product is classified as a veterinary medicine approved by regulatory bodies for use only in specific livestock populations, such as cattle and swine, for their indicated conditions.

How should Nuflor be stored and disposed of?

Storage and Disposal Requirements

Nuflor (Florfenicol Injectable Solution) must be stored under specific environmental and temperature conditions as defined by regulatory labeling.

Storage Conditions

The product must be stored at a temperature between 2 C and 30 C (36 F and 86 F). The solution must be protected from light and it is required that the product not be frozen.

Condition	Requirement
Temperature	2 C to 30 C
Protection	Protect from light; Do not freeze

Stability and Disposal

The injectable solution should be kept out of the sight and reach of children. After the vial stopper is first punctured, the solution must be used within 30 days. Unused or expired product must be disposed of in accordance with local requirements and should not be disposed of via wastewater.

Nuflor